---
figid: PMC10949665__13018_2024_4640_Fig6_HTML
figtitle: Glaucocalyxin A delays the progression of OA by inhibiting NFKB and MAPK
  signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10949665
filename: 13018_2024_4640_Fig6_HTML.jpg
figlink: /pmc/articles/PMC10949665/figure/F6
number: F6
caption: This model demonstrates that GLA is a promising medication for the treatment
  of OA by blocking the NF-κB, ERK, and JNK pathways in chondrocytes to reduce inflammatory
  factor production and maintain extracellular homeostasis
papertitle: Glaucocalyxin A delays the progression of OA by inhibiting NF-κB and MAPK
  signaling pathways
reftext: Xin Hong, et al. J Orthop Surg Res. 2024;19(NA).
year: '2024'
doi: 10.1186/s13018-024-04640-z
journal_title: Journal of Orthopaedic Surgery and Research
journal_nlm_ta: J Orthop Surg Res
publisher_name: BioMed Central
keywords: OA | Glaucocalyxin A | NF-κB | MAPK | Extracellular matrix
automl_pathway: 0.9445972
figid_alias: PMC10949665__F6
figtype: Figure
redirect_from: /figures/PMC10949665__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10949665__13018_2024_4640_Fig6_HTML.html
  '@type': Dataset
  description: This model demonstrates that GLA is a promising medication for the
    treatment of OA by blocking the NF-κB, ERK, and JNK pathways in chondrocytes to
    reduce inflammatory factor production and maintain extracellular homeostasis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOX9
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - IL18
  - NFKBIA
  - EPHB2
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - CASP1
  - NFE2
  - PSMC5
  - SKP2
  - NFKB1
  - COX2
  - PTGS2
  - MTCO2P12
  - NOS2
  - ISYNA1
  - Osteoarthritis
---
